121 related articles for article (PubMed ID: 7587707)
1. Dyes providing increased sensitivity in flow-cytometric dye-efflux assays for multidrug resistance.
Frey T; Yue S; Haugland RP
Cytometry; 1995 Jul; 20(3):218-27. PubMed ID: 7587707
[TBL] [Abstract][Full Text] [Related]
2. Rhodamine 123: is it an appropriate dye to study P-glycoprotein activity in adriamycin-resistant K562 cells?
Denis-Gay M; Petit JM; Ratinaud MH
Anticancer Res; 1995; 15(1):121-6. PubMed ID: 7733620
[TBL] [Abstract][Full Text] [Related]
3. DiOC2(3) is not a substrate for multidrug resistance protein (MRP)-mediated drug efflux.
Minderman H; Vanhoefer U; Toth K; Yin MB; Minderman MD; Wrzosek C; Slovak ML; Rustum YM
Cytometry; 1996 Sep; 25(1):14-20. PubMed ID: 8875050
[TBL] [Abstract][Full Text] [Related]
4. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric assessment of the cellular pharmacokinetics of fluorescent drugs.
Dordal MS; Ho AC; Jackson-Stone M; Fu YF; Goolsby CL; Winter JN
Cytometry; 1995 Aug; 20(4):307-14. PubMed ID: 7587718
[TBL] [Abstract][Full Text] [Related]
6. Characterization of multidrug resistance by fluorescent dyes.
Kessel D; Beck WT; Kukuruga D; Schulz V
Cancer Res; 1991 Sep; 51(17):4665-70. PubMed ID: 1873811
[TBL] [Abstract][Full Text] [Related]
7. P-glycoprotein mediated multidrug resistance assessment by flow-cytometry in malignant hemopathies.
Tatu CA; Paunescu V; Stanescu DI; Schneider F
Anticancer Res; 1997; 17(4A):2583-6. PubMed ID: 9252684
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric determination of the multidrug-resistant phenotype in acute leukemia.
Maslak P; Hegewisch-Becker S; Godfrey L; Andreeff M
Cytometry; 1994 Sep; 17(1):84-93. PubMed ID: 8001461
[TBL] [Abstract][Full Text] [Related]
9. Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen.
Lee JS; Paull K; Alvarez M; Hose C; Monks A; Grever M; Fojo AT; Bates SE
Mol Pharmacol; 1994 Oct; 46(4):627-38. PubMed ID: 7969041
[TBL] [Abstract][Full Text] [Related]
10. Characterization of four drug-resistant P388 sublines: resistance/sensitivity in vivo, resistance-and proliferation-markers, immunogenicity.
Fichtner I; Stein U; Hoffmann J; Winterfeld G; Pfeil D; Hentschel M
Anticancer Res; 1994; 14(5A):1995-2003. PubMed ID: 7847840
[TBL] [Abstract][Full Text] [Related]
11. Effects of vinblastine, colchicine, and verapamil on rhodamine 123 accumulation in human P-glycoprotein-positive leukemia cells.
Lautier D; Canitrot Y; Salmon JM
Anticancer Res; 1994; 14(6B):2589-95. PubMed ID: 7872686
[TBL] [Abstract][Full Text] [Related]
12. Interaction of tomato lectin with ABC transporter in cancer cells: glycosylation confers functional conformation of P-gp.
Molnár J; Kars MD; Gündüz U; Engi H; Schumacher U; Van Damme EJ; Peumans WJ; Makovitzky J; Gyémánt N; Molnár P
Acta Histochem; 2009; 111(4):329-33. PubMed ID: 19124148
[TBL] [Abstract][Full Text] [Related]
13. Exploring multidrug resistance using rhodamine 123.
Kessel D
Cancer Commun; 1989; 1(3):145-9. PubMed ID: 2639727
[TBL] [Abstract][Full Text] [Related]
14. Modulation of P-glycoprotein-mediated multidrug resistance by acceleration of passive drug permeation across the plasma membrane.
Regev R; Katzir H; Yeheskely-Hayon D; Eytan GD
FEBS J; 2007 Dec; 274(23):6204-14. PubMed ID: 17986257
[TBL] [Abstract][Full Text] [Related]
15. Reversal of drug resistance in P-glycoprotein-expressing T-cell acute lymphoblastic CEM leukemia cells by copper N-(2-hydroxy acetophenone) glycinate and oxalyl bis (N-phenyl) hydroxamic acid.
Majumder S; Dutta P; Mukherjee P; Datta ER; Efferth T; Bhattacharya S; Choudhuri SK
Cancer Lett; 2006 Nov; 244(1):16-23. PubMed ID: 16410038
[TBL] [Abstract][Full Text] [Related]
16. Multidrug resistance reversal in mouse lymphoma cells by heterocyclic compounds.
Molnár J; Szabo D; Mándi Y; Mucsi I; Fischer J; Varga A; König S; Motohashi N
Anticancer Res; 1998; 18(4C):3033-8. PubMed ID: 9713505
[TBL] [Abstract][Full Text] [Related]
17. Modulation of doxorubicin resistance in P388/ADR cells by Ro44-5912, a tiapamil derivative.
De Jong G; Gelmon K; Bally M; Goldie J; Mayer L
Anticancer Res; 1995; 15(3):911-6. PubMed ID: 7645981
[TBL] [Abstract][Full Text] [Related]
18. [Flow cytometric analysis of P-glycoprotein function by rhodamine 123 dye-efflux assay in human leukemia cells].
Kawabata M; Kobayashi H; Mori S; Sekiguchi S; Takemura Y
Rinsho Byori; 1997 Sep; 45(9):891-8. PubMed ID: 9311264
[TBL] [Abstract][Full Text] [Related]
19. Anti-CD19 antibodies inhibit the function of the P-gp pump in multidrug-resistant B lymphoma cells.
Ghetie MA; Ghetie V; Vitetta ES
Clin Cancer Res; 1999 Dec; 5(12):3920-7. PubMed ID: 10632321
[TBL] [Abstract][Full Text] [Related]
20. [Multidrug resistance of leukemia cells to cytostatics--the functional fluorescent dye efflux assay evaluated by flow cytometry].
Jankovicová K; Krejsek J; Kopecký O
Vnitr Lek; 2001 Jan; 47(1):25-9. PubMed ID: 15635865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]